Abstract
Regenerative Medicine Heart failure is caused by injury to the myocardium, the heart muscle, which results in irreversible loss because this tissue cannot regenerate itself. Bargehr et al. investigated whether regenerative medicine approaches involving human embryonic stem cell (hESC)–derived epicardial cells, which produce stromal cells, smooth muscle cells, and growth factors, can remuscularize injured heart. They showed that hESC-derived epicardial cells improved the structure and function of heart tissue in vitro and improved hESC-derived cardiomyocyte grafts in rats with heart tissue loss. The improvements to heart function in vivo persisted for 3 months, suggesting an approach for improving heart regenerative medicine. Nat. Biotech. 37 , 895 (2019).
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
